IL4 and atherosclerosis: Seven core targets-IFNG, CXCL8, TNF, TGFB1, IL2, IL4, and RELA-were identified via network pharmacology, involving key pathways such as lipid-atherosclerosis, AGE-RAGE, and IL-17 signaling.